drugset / Trial / NCT01206608
Evaluation of the Safety and Efficacy of a Single Dose of SKY0402 in Subjects Undergoing Augmentation Mammoplasty
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of this study was to demonstrate the superiority of SKY0402 over conventional, commercially-available bupivacaine HCl with respect to the duration of the analgesic effect achieved by a single local administration of the study drug.
Timeline
- Start
- 2008-03
- Primary completion
- 2008-08
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 75 mg | Other |
| Comparator | SKY0402 | Unknown | — | Other |
Indications
No indication recorded.